VA Peg-Intron registry
Executive Summary
Schering-Plough's Peg-Intron (peginterferon alfa-2b) patient registration program will last six to 12 months, Department of Veterans Affairs estimates. VA has established its own registration program, which does not include patient-specific data, because it objected to the amount of information Schering's program was collecting 1("The Pink Sheet" Nov. 5, 2001, p. 20)...
You may also be interested in...
PEG-Intron Access Program Requires ID Number, Designed To Ensure Supply
Schering-Plough is implementing a prescription tracking program for PEG-Intron to ensure that existing patients will have adequate supply of peginterferon alfa-2b
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.